Skip to main content
SpringerLink
Log in

The international Unity study for antivirals against mpox is a blueprint for future epidemics

  • Correspondence
  • Published:

From Nature Medicine

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Girometti, N. et al. Lancet Infect. Dis. 22, 1321–1328 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. World Health Organization. https://worldhealthorg.shinyapps.io/mpx_global/ (accessed 5 February 2023).

  3. Tomori, O. & Ogoina, D. Science 377, 1261–1263 (2022).

    Article  CAS  PubMed  Google Scholar 

  4. World Health Organization. go.nature.com/3BWl8ji (2022).

  5. World Health Organization. go.nature.com/3N5Yvzj (2022).

Download references

Author information

Authors and Affiliations

  1. ANRS|Emerging Infectious Diseases/Inserm, Paris, France

    Erica Telford, Nicolas Pulik, Alpha Diallo & Yazdan Yazdanpanah

  2. Instituto Nacional de Infectologia Evandro Chagas, FIOCRUZ, Rio de Janeiro, Brazil

    Beatriz Grinsztejn

  3. Department of Research Support for Clinical Trials, Oslo University Hospital, Oslo, Norway

    Inge Christoffer Olsen

  4. Département d’Épidémiologie, Biostatistique et Recherche Clinique, Hôpital Bichat, AP-HP, Paris, France

    France Mentré & Skerdi Haviari

  5. Université de Paris, IAME, Inserm, Paris, France

    France Mentré & Yazdan Yazdanpanah

  6. HIV/AIDS Unit, Infectious Diseases Division, Geneva University Hospitals, Geneva, Switzerland

    Maxime Hentzien, Olivier Ségéral & Alexandra Calmy

  7. Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands

    Miquel B. Ekkelenkamp

  8. Infectious Diseases Unit, Department of Internal Medicine, Niger Delta University/Niger Delta University Teaching Hospital, Bayelsa, Nigeria

    Dimie Ogoina

  9. PANTHER, Paris, France

    Nathalie Strub-Wourgaft

  10. Service de Maladies Infectieuses et Tropicales, Hôpital Bichat, AP-HP, Paris, France

    Yazdan Yazdanpanah

Authors
  1. Erica Telford
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Beatriz Grinsztejn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Inge Christoffer Olsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nicolas Pulik
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. France Mentré
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Skerdi Haviari
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Maxime Hentzien
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Olivier Ségéral
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Miquel B. Ekkelenkamp
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Dimie Ogoina
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Nathalie Strub-Wourgaft
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Alpha Diallo
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Yazdan Yazdanpanah
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Alexandra Calmy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexandra Calmy.

Ethics declarations

Competing interests

M.H. received travel fees and/or honorary for lectures from Gilead Science, ViiV Healthcare, Mylan, MSD and Menarini in the past 3 years. Y.Y. has been a board member receiving consultancy fees from AbbVie, BMS, Gilead, MSD, J&J, Pfizer and ViiV Healthcare; all of these activities stopped in the past 4 years. All other authors declare no conflicts.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Telford, E., Grinsztejn, B., Olsen, I.C. et al. The international Unity study for antivirals against mpox is a blueprint for future epidemics. Nat Med 29, 1894–1895 (2023). https://doi.org/10.1038/s41591-023-02393-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-023-02393-6

  • Springer Nature America, Inc.

Search

Navigation